142 related articles for article (PubMed ID: 6619829)
1. The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced increases in locomotor activity.
Feigenbaum JJ; Yanai J; Klawans HL
J Neural Transm; 1983; 57(1-2):27-37. PubMed ID: 6619829
[TBL] [Abstract][Full Text] [Related]
2. The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced locomotor activity.
Feigenbaum JJ; Yanai J; Klawans HL
J Neural Transm; 1982; 54(3-4):145-51. PubMed ID: 7130970
[No Abstract] [Full Text] [Related]
3. Possible dopamine agonist properties of quipazine maleate.
Feigenbaum JJ; Yanai J; Klawans HL
Int J Neurosci; 1983; 18(3-4):205-10. PubMed ID: 6222999
[TBL] [Abstract][Full Text] [Related]
4. Reduced head-twitch response to quipazine of rats previously treated with methiothepin: possible involvement of dopaminergic system.
Dall'Olio R; Vaccheri A; Montanaro N
Pharmacol Biochem Behav; 1985 Jul; 23(1):43-8. PubMed ID: 2994121
[TBL] [Abstract][Full Text] [Related]
5. Effects of serotonergic agonists and antagonists on the locomotor activity of neonatal rats.
Lucot JB; Seiden LS
Pharmacol Biochem Behav; 1986 Mar; 24(3):537-41. PubMed ID: 3486425
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic activity of quipazine.
Schechter MD; Concannon JT
Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
[TBL] [Abstract][Full Text] [Related]
7. Is there a "serotonergic syndrome" in neonatal rat pups?
Ristine LA; Spear LP
Pharmacol Biochem Behav; 1985 Feb; 22(2):265-9. PubMed ID: 2858868
[TBL] [Abstract][Full Text] [Related]
8. The combined effect of quipazine and haloperidol on plasma prolactin release.
Feigenbaum J; Yanai J; Klawans HL; Chatterton R
Int J Neurosci; 1983; 18(1-2):37-40. PubMed ID: 6840980
[TBL] [Abstract][Full Text] [Related]
9. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
Langlais PJ; Gabay S
J Neurosci Res; 1977; 3(2):135-41. PubMed ID: 563925
[TBL] [Abstract][Full Text] [Related]
10. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
Green AR; Hall JE; Rees AR
Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
[TBL] [Abstract][Full Text] [Related]
11. The effects of serotonergic drugs on the locomotor pattern and on cutaneous reflexes of the adult chronic spinal cat.
Barbeau H; Rossignol S
Brain Res; 1990 Apr; 514(1):55-67. PubMed ID: 2357531
[TBL] [Abstract][Full Text] [Related]
12. Effects of metergoline and quipazine on locomotor activity of rats in novel and familiar environments.
Beninger RJ
Pharmacol Biochem Behav; 1984 May; 20(5):701-5. PubMed ID: 6739514
[TBL] [Abstract][Full Text] [Related]
13. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
Eison AS; Eison MS; Yocca FD; Gianutsos G
Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
[TBL] [Abstract][Full Text] [Related]
15. Effects of quipazine and methysergide on play in juvenile rats.
Normansell L; Panksepp J
Pharmacol Biochem Behav; 1985 May; 22(5):885-7. PubMed ID: 2989950
[TBL] [Abstract][Full Text] [Related]
16. Tonic immobility in domestic fowl: anticataleptic effects of quipazine.
Wallnau LB
Pharmacol Biochem Behav; 1980 Mar; 12(3):347-52. PubMed ID: 7190287
[TBL] [Abstract][Full Text] [Related]
17. Effects of the serotonin agonist, quipazine, on luteinizing hormone and prolactin release: evidence for serotonin-catecholamine interactions.
Lynch CO; Johnson MD; Crowley WR
Life Sci; 1984 Oct; 35(14):1481-7. PubMed ID: 6148678
[TBL] [Abstract][Full Text] [Related]
18. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.
Carlton J; Rowland N
Pharmacol Biochem Behav; 1984 May; 20(5):739-45. PubMed ID: 6610879
[TBL] [Abstract][Full Text] [Related]
19. Comparison of anorexia and motor disruption by cyclazocine and quipazine.
Henck JW; Rezabek DH; Rech RH
Pharmacol Biochem Behav; 1985 May; 22(5):671-6. PubMed ID: 4011631
[TBL] [Abstract][Full Text] [Related]
20. Quipazine-induced behavior in neonatal rat pups.
Spear LP; Ristine LA
Pharmacol Biochem Behav; 1981 Jun; 14(6):831-4. PubMed ID: 7255519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
